Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118523) titled 'Exploration of Risk Prediction Model Tools for Chemotherapy-Induced Peripheral Neuropathy:A Retrospective Study' on Feb. 6.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Zhongshan Hospital Affiliated to Xiamen University
Condition:
Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Intervention:
no-CIPN group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-27
Target Sample Size: no-CIPN group:100;CIPN group:200;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=297124
Disclaimer: Curate...